Developing a non-invasive diagnostic framework for the fractional flow reserve quantification in left coronary

M Fernandes1,2, F P Oliveira1,2, N D Ferreira3

  • 1Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, Porto, Portugal.

Insights

This study introduces a new computational tool to predict fractional flow reserve (FFR) non-invasively using CT scans. The tool shows high accuracy and stability, offering a promising alternative to invasive methods for diagnosing coronary artery disease (CAD).

Area of Science:

  • Cardiovascular Imaging and Modeling
  • Computational Fluid Dynamics (CFD)
  • Medical Device Technology

Background:

  • Coronary artery disease (CAD) is a leading cause of mortality worldwide.
  • Current hemodynamic assessment via invasive fractional flow reserve (FFR) presents significant costs and clinical challenges.
  • Non-invasive diagnostic alternatives are highly sought after for CAD assessment.

Purpose of the Study:

  • To develop and validate a novel computational tool for non-invasively predicting patient-specific FFR from CT-derived coronary models.
  • To assess the accuracy and stability of the developed tool compared to invasive FFR and commercial software.

Main Methods:

  • Utilized patient-specific 3D coronary models segmented from CT scans.
  • Employed computational fluid dynamics (CFD) with physiologically informed boundary conditions and a viscoelastic blood model.
  • Simulated hyperemic conditions and compared predictions against invasive FFR and HeartFlow® data in 12 patients.

Main Results:

  • Achieved a high correlation (R² = 0.978) with invasive FFR measurements.
  • Demonstrated a low average relative error (3.86% ± 2.01%) and negligible bias (-0.015) via Bland-Altman analysis.
  • Exhibited improved stability and lower variability compared to commercial HeartFlow® data.

Conclusions:

  • The developed numerical tool shows significant potential for accurately approximating hyperemic coronary dynamics non-invasively.
  • This framework offers a cost-effective, on-site solution for assessing stenosis severity and aiding CAD diagnosis.
  • Further validation through larger, multi-center clinical trials is necessary to establish definitive accuracy and generalizability.
Abstract

Related Concept Videos